Osiris Therapeutics (OSIR) to Sell Mesenchymal Stem Cell UnitStreetInsider.com (subscription)Osiris Therapeutics, Inc. (Nasdaq: OSIR) and Mesoblast Limited, through its wholly owned subsidiary, Mesoblast International Sárl (“Mesoblast”), entered into a Purchase Agreement, dated October 10, 2013, pursuant to the terms of which the Company sold … …read more &nbs… Continue reading
Mesoblast Rises on Plan to Buy Stem–Cell Business: Sydney MoverBloombergMesoblast Ltd. (MSB) climbed the most in eight months in Sydney trading after agreeing to buy a stem–cell business of Osiris Therapeutics Inc. (OSIR) for as much as $100 million to gain new treatments. The maker of stem–cell therapies rose as much as … …read more &nbs… Continue reading
Mesoblast Acquires Culture Expanded Stem Cell Therapeutic Business from OsirisBenzingaMesoblast Limited (OTC: MBLTY) today announced the acquisition of the entire culture-expanded mesenchymal stem cell (MSC) business of Osiris Therapeutics (NASDAQ: OSIR) by the Mesoblast Group. “The many commercial and strategic benefits of this … …read more &nbs… Continue reading
NewsdayLong Island medical investigators are embarking on a study that involves infusing 10 million stem cells directly into a coronary artery of heart attack patients in an effort to regenerate tissue that otherwise would be forever damaged. Regeneration has … …read more &nbs… Continue reading
Motherboard (blog)The problem with neurological research is that the brain is kind of a tough organ to study without, you know, killing someone. And the human brain is so advanced that studying diseases like Parkinson’s and Alzheimer’s in mice and primates doesn’t …Scientists stop brain cells in mice from dying in potential Alzheimer’s …Fox News‘Historic … Continue reading
Stomach cells naturally revert to stem cellsScience Daily (press release)Oct. 10, 2013 — New research has shown that the stomach naturally produces more stem cells than previously realized, likely for repair of injuries from infections, digestive fluids and the foods we eat. and more …read more &nbs… Continue reading
Mesoblast to aquire further stem cell assetsSydney Morning HeraldStem cell group Mesoblast is to outlay up to $US100 million on a US acquisition as it ramps up its product development pipeline and broadens its suite of patents. It is to acquire the stem cell assets of Osiris Therapeutic for an initial $US20 million …Osiris Announces … Continue reading
Minerva Biotechnologies to Give Company Presentation at 2013 Stem Cell …PharmiWeb.com (press release)Minerva Biotechnologies announced today that Dr. Cynthia Bamdad will give a company presentation at the 3rd Annual Regen Med Partnering Forum part of the Stem Cell Meeting on the Mesa to be held October 14-16 in La Jolla CA. Minerva is focused on … Continue reading